Medical Research
(H99)
PHARE BIO INC
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2023
$2.0M
Total Revenue
$1.2M
Total Expenses
$1.7M
Net Assets
3
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
72.1%
Fundraising Efficiency
0.0%
Operating Reserve
16.80x
Liability-to-Asset
4.8%
Revenue Diversification
99.9%
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $2.0M | $1.2M | $1.7M | 72.1% | 3 |
| 2022 | $1.6M | $1.2M | N/A | — | 2 |
| 2019 | $0 | $0 | N/A | — | 1 |
Donor Reviews
No reviews yet
Be the first to share your experience with this organization.